Welcome to our dedicated page for Carpenter Technology SEC filings (Ticker: CRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Carpenter Technology’s raw-material exposure and aerospace order flow can feel like metallurgy itself—dense, technical, and time-consuming. Each 250-page filing breaks down nickel, titanium, and specialty steel costs across the Specialty Alloys Operations (SAO) and Performance Engineered Products (PEP) segments, leaving investors searching for what truly moves CRS shares.
Our platform solves that problem. The moment a Carpenter Technology quarterly earnings report 10-Q filing or Carpenter Technology annual report 10-K hits EDGAR, Stock Titan’s AI extracts segment profit, backlog trends, and hedging details—turning legal prose into plain-language insights. Need to monitor Carpenter Technology insider trading Form 4 transactions? Real-time alerts highlight executive buys and sells, while AI-powered summaries explain the context behind every trade. Material events? The next Carpenter Technology 8-K material events explained arrives with key takeaways already highlighted.
Whether you’re comparing SAO margins quarter-over-quarter, checking a Carpenter Technology proxy statement executive compensation, or simply understanding Carpenter Technology SEC documents with AI, you’ll find every filing type here—10-K, 10-Q, 8-K, S-3, DEF 14A, and especially Carpenter Technology Form 4 insider transactions real-time. Analysts use these insights to price alloy demand, portfolio managers spot trend-shifting insider activity, and engineers confirm material specs—all without wading through hundreds of pages. Complex filings made clear, updated in real time, and explained in the language of investors.
Form 4 filing for UnitedHealth Group (UNH) dated 07/02/2025 discloses routine quarterly equity compensation to non-employee director Paul R. Garcia.
- Transactions (07/01/2025): 173 deferred stock units (immediately vested, must be held until board service ends) and 96 shares of common stock, both awarded at $0 cost.
- Post-transaction ownership: 2,750 common shares held directly; 2,146 shares in a revocable trust; 45 and 55 shares in two additional trusts, for a total indirect holding of 2,246 shares.
- No derivative securities were acquired or disposed of; the filing cites the awards as regular quarterly director compensation, not incentive-based or market purchases.
The filing is administrative in nature, with no impact on company operations, capital structure, or insider sentiment beyond customary board compensation.
Upstart Holdings, Inc. (UPST) – Form 144 insider notice
Insider Natalia Mirgorodskaya has filed to sell up to 6,533 common shares through Charles Schwab on or about 07/02/2025. At the reference price used in the filing, the transaction is valued at roughly $457,674. The shares were obtained the same day via an employee stock-option cashless exercise. Mirgorodskaya also disclosed two prior sales in the last three months—764 shares for $35,874 on 05/20/2025 and 1,340 shares for $59,215 on 05/23/2025.
With 95,144,858 shares outstanding, the proposed sale represents approximately 0.007 % of total shares, indicating a limited potential impact on the float. The filer certified that no undisclosed adverse information is known, in accordance with Rule 144 requirements.